Trials / Completed
CompletedNCT06069609
Orientation Characteristics of Daily Disposable Toric Contact Lenses
Orientation Characteristics of Kalifilcon A Daily Disposable Toric Contact Lenses Compared to Acuvue Oasys 1-Day for Astigmatism Contact Lenses
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Brief summary: Approximately 30 soft toric contact lens adapted subjects will be enrolled in this feasibility, bilateral, randomized, double-masked (subject and investigator), repeated measures insertion study.
Detailed description
Approximately 30 soft toric contact lens adapted subjects will be enrolled in this feasibility, bilateral, randomized, double-masked (subject and investigator), repeated measures insertion study. All subjects will be seen for a Screening/Dispensing Visit at which informed consent will be obtained and eligibility will be assessed. If subjects satisfy all eligibility criteria, subjects will be dispensed study lenses according to unique randomization tables that will be provided to each Investigator. If study eligibility is met, subjects will have lenses inserted in random, successive order. Subjects will be receiving each of the study lens types once, in a randomized order. The subject will wear each of the study contact lenses for approximately 10 minutes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | kalifilcon A Daily Disposable Toric | kalifilcon A Daily Disposable Toric |
| DEVICE | Acuvue Oasys 1-Day for Astigmatism | Acuvue Oasys 1-Day for Astigmatism |
Timeline
- Start date
- 2023-08-11
- Primary completion
- 2023-08-15
- Completion
- 2023-08-15
- First posted
- 2023-10-06
- Last updated
- 2025-07-01
- Results posted
- 2025-07-01
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06069609. Inclusion in this directory is not an endorsement.